F2RL1 and hepatocellular carcinoma: Compared with the paired nontumor tissues, high levels (defined as greater than twofold increase) of PAR2 expression in 143 of 208 (68.8%) HCC cases, and the other 65 (31.2%) were defined as PAR2 low expression group.